Ahrén B. Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors. idn [Internet]. 2013Feb.1 [cited 2024May3];10(1):31-6. Available from: https://internationaldiabetesnursing.org/index.php/idn/article/view/234